The Current Ratio as of December 2025 (TTM) for Tien Liang BioTech Co., Ltd. (4127.TWO) is 0.51

According to Tien Liang BioTech Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.51. This represents a change of -38.20% compared to the average of 0.82 of the last 4 quarters.

Tien Liang BioTech Co., Ltd. (4127.TWO) Historical Current Ratio (quarterly & annually)

How has 4127.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Tien Liang BioTech Co., Ltd. over the last ten years is 1.14. The current 0.51 Current Ratio has changed 4.33% with respect to the historical average. Over the past ten years (40 quarters), 4127.TWO's Current Ratio was at its highest in in the March 2024 quarter at 2.25. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

Tien Liang BioTech Co., Ltd. (4127.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tien Liang BioTech Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tien Liang BioTech Co., Ltd. (4127.TWO) Average Current Ratio

How has 4127.TWO Current Ratio performed in the past?

The current Current Ratio of Tien Liang BioTech Co., Ltd. (4127.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tien Liang BioTech Co., Ltd. (4127.TWO) Current Ratio vs. Peers

How is 4127.TWO’s Current Ratio compared to its peers?

Tien Liang BioTech Co., Ltd.’s Current Ratio is less than Anxo Pharmaceutical Co., Ltd. (1.68), less than Excelsior Biopharma Inc. (3.40), less than Prince Pharmaceutical Co., Ltd. (1.63), less than Allied Biotech Corporation (1.51), less than Enimmune corporation (1.41), less than DV Biomed Co., Ltd. (3.36), less than NaviFUS Corp. (15.39), less than Bioptik Technology Incorporation (2.07), less than Genetics Generation Advancement Corp. (2.68), less than Lagis Enterprise Co., Ltd. (1.79),

Build a custom stock screener for Tien Liang BioTech Co., Ltd. (4127.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tien Liang BioTech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tien Liang BioTech Co., Ltd. (4127.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tien Liang BioTech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.